30/03/2015 01:51:17 Free Membership Login

Merck News (NYSE:MRK)

DateTimeSource
Headline
03/29/201510:02AMTMFIs Gilead Sciences Inc. About to Crater Before Our Very Eyes?
http://www.fool.com/investing/general/2015/03/29/is-gilead-sciences-inc-about-to-crater-before-our.aspx?source=eptadnlnk0000002 More...>>
03/29/20153:44AMSEEKMerck: Buyback Plan Not As Impressive As It Appears
http://seekingalpha.com/article/3035116-merck-buyback-plan-not-as-impressive-as-it-appears?source=partner_advfn More...>>
03/28/20152:02PMTMFOut of 12 Big Pharma Stocks, This is the 1 You Can Confidently Hold for the Next 10 Years
http://www.fool.com/investing/general/2015/03/28/out-of-12-big-pharma-stocks-this-is-the-1-you-can.aspx?source=eptadnlnk0000002 More...>>
03/27/20159:19AMSEEKEbola vaccine candidates pass safety test in in Liberia trials
http://seekingalpha.com/news/2395976-ebola-vaccine-candidates-pass-safety-test-in-in-liberia-trials?source=partner_advfn More...>>
03/27/20158:00AMBWMerck to Hold First-Quarter 2015 Sales and Earnings Conference Call on April 28
Merck (NYSE: MRK), known as MSD outside the United States and Canada, will hold its first-quarter 2015 sales and earnings conference call with institutional investors and analysts at 8:00 a.m. EDT on Tuesday, April 28. During the call, company executives will provide an overview of Merck’s performance for the quarter... More...>>
03/27/20157:58AMTMFIs This Tiny Biotech Still a Buy at All-Time Highs?
http://www.fool.com/investing/general/2015/03/27/is-this-tiny-biotech-still-a-buy-at-all-time-highs.aspx?source=eptadnlnk0000002 More...>>
03/26/20158:30AMBWMerck Announces Collaboration with the American Diabetes Association to Educate Adults with Diabetes About Increased Risk for...
Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced a collaboration with the American Diabetes Association (ADA). The collaboration aims to educate adults with diabetes about their increased risk for potentially serious health problems, including pneumococcal pneumonia, influenza (flu... More...>>
03/25/20157:09PMDJNInvestors Scoop Up Companies' Bonds
By Mike Cherney Investors a re scooping up U.S. corporate bonds at a record first-quarter pace, as companies tap the market to finance a wave of big health-care acquisitions. Investment-grade and junk-rated companies combined have sold $438 billion of new bonds this year through Tuesday, according to data provider Dealogic... More...>>
03/25/20158:48AMSEEKMerck's Dividend Has Recovered From Pre-Recession Problems
http://seekingalpha.com/article/3027066-mercks-dividend-has-recovered-from-pre-recession-problems?source=partner_advfn More...>>
03/25/20156:30AMSEEKWall Street Breakfast: Kraft, Heinz Announce Mega Merger
http://seekingalpha.com/article/3026606-wall-street-breakfast-kraft-heinz-announce-mega-merger?source=partner_advfn More...>>
03/24/20155:58PMDJNMerck Increases Buyback Authorization by $10 Billion
By Josh Beckerman Merck & Co. has increased its stock-buyback authorization by $10 billion, a move the company said "reiterates our confidence in the company's long-term business strategy and future prospects." Merck's repurchase authorization now stands at $11.7 billion, including about $1.7 billion remaining under... More...>>
03/24/20155:00PMBWMerck Announces New $10 Billion Share Repurchase Program
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that its board of directors has authorized additional purchases of up to $10 billion of Merck’s common stock for its treasury. The treasury stock purchase has no time limit and will be made over time in open-market transactions, block... More...>>
03/24/20159:08AMSEEKMerck's Keytruda tops Bristol-Myers' Yervoy in melanoma trial
http://seekingalpha.com/news/2387966-mercks-keytruda-tops-bristol-myers-yervoy-in-melanoma-trial?source=partner_advfn More...>>
03/24/20158:30AMBWMerck’s Pivotal KEYNOTE-006 Study in First-Line Treatment for Advanced Melanoma Met Co-Primary Endpoints & Will be Stopped ...
KEYTRUDA Demonstrated Superior Overall Survival and Progression-Free Survival Compared to Ipilimumab Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the randomized, pivotal Phase 3 study (KEYNOTE-006) investigating KEYTRUDA® (pembrolizumab) compared to ipilimumab in the first-line... More...>>
03/22/201511:01AMTMF3 Things You Need to Know About Achillion Pharmaceuticals Inc.
http://www.fool.com/investing/general/2015/03/22/3-things-you-need-to-know-about-achillion-pharmace.aspx?source=eptadnlnk0000002 More...>>
03/21/20158:11AMTMFWhy Pfizer Inc. Isn't Built to Last
http://www.fool.com/investing/general/2015/03/21/why-pfizer-inc-isnt-built-to-last.aspx?source=eptadnlnk0000002 More...>>
03/20/201510:02AMPRNUSAward-Winning Actress S. Epatha Merkerson and Merck Challenge African Americans with Type 2 Diabetes to Get to Their Goals
Award-Winning Actress S. Epatha Merkerson and Merck Challenge African Americans with Type 2 Diabetes to Get to Their Goals Merkerson Visits Memphis, Tennessee on March 20 With America's Diabetes Challenge: Get to Your Goals Program PR Newswire KENILWORTH, N.J., March 20, 2015 KENILWORTH, N.J., March 20, 2015 /PRNewswire/... More...>>
03/18/20154:19PMBWNew Data Investigating Merck’s KEYTRUDA® (pembrolizumab) in Advanced Non-Small Cell Lung Cancer & Mesothelioma to Be Prese...
Data to be Presented Across Multiple Tumor Types for KEYTRUDA and MK-8628 (OTX015), an Investigational BET-Bromodomain Inhibitor Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that new data evaluating KEYTRUDA® (pembrolizumab), the company’s anti-PD-1 therapy, in both advanced non-small... More...>>
03/18/20157:59AMTMFWhy I'm Not Giving Up on This Tiny Biotech Stock (Yet)
http://www.fool.com/investing/general/2015/03/18/why-im-not-giving-up-on-this-tiny-biotech-stock-ye.aspx?source=eptadnlnk0000002 More...>>
03/18/20157:30AMSEEKTrend Is Not Your Friend - Cramer's Mad Money (3/17/15)
http://seekingalpha.com/article/3009486-trend-is-not-your-friend-cramers-mad-money-3-17-15?source=partner_advfn More...>>


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nyse mrk150330 01:51